$OMER ...Regarding the possible comparison of ACAD's recent CRL to OMER's current pending BLA awaiting approval, not sure the FDA would have allowed Narsoplimab to be used in the I-SPY government funded Covid-19 Critically-ill Trial if they had any questions about it's efficacy or proven therapeutic value. Just my opinion....
2
17
17 Likes